share_log

Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a

Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a

Karyopharm宣佈再融資交易2025年到期的現有可轉換票據的1.48億美元將交換2029年到期的1.11億美元新可轉換票據和認股權證,發行2028年到期的1億美元新優先有擔保定期貸款a
Benzinga ·  05/08 07:39

Karyopharm Announces Refinancing Transactions $148M Of Existing Convertible Notes Due In 2025 To Be Exchanged for $111M Of New Convertible Notes Due In 2029 And Warrants, Issues New $100M Senior Secured Term Loan Due in 2028a

Karyopharm宣佈再融資交易2025年到期的現有可轉換票據的1.48億美元將交換2029年到期的1.11億美元新可轉換票據和認股權證,發行2028年到期的1億美元新優先有擔保定期貸款a

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論